Shay Shemesh, Chief Development & Operations Officer at Nuvectis Pharma, Inc. (NVCT), bought 242 shares at $19.55 ($5K) on 2022-05-17, disclosed to the SEC on 2022-05-18.
Open-market purchase of $5k NVCT by Chief Development & Operations Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.28 | 100 | $2K | 41.0% |
| 2 | $19.55 | 142 | $3K | 59.0% |
| Total | $19.44 avg | 242 | $5K | 100% |
| Filing → |
| NVCT | BUY | 2023-03-17 | $7K | — | Filing → |
| NVCT | BUY | 2022-12-22 | $4K | — | Filing → |
| NVCT | BUY | 2022-11-18 | $2K | — | Filing → |